CD8A and Autoimmunity: Autoreactive CD8 T cell activation after PD-1 ICB induces autoimmune diabetes in Rip-mOVA mice indicating that loss of CD8 T cell self-tolerance following immune modulation therapies increases autoimmunity (88).